Updated Nov 4, 2026FDA and CMS public dataIndependent · free · not health advice
GxRadar
Drugs/Cyclobenzaprine 10 mg tablet
Muscle relaxant

Cyclobenzaprine 10 mg tablet

Public data on cyclobenzaprine from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.

$0.0172
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-30%
change over five years
peak $0.0277 in 2014-12
23
approved generic applications (ANDAs) on record for Cyclobenzaprine Hydrochloride
16 with a product still marketed · first 1988
Not listed
in FDA's current shortage list
no matching FDA shortage entries

NADAC per unit, monthly

CYCLOBENZAPRINE 10 MG TABLET
Show as table
MonthNADAC per unit ($)
2013-110.02241
2014-020.02756
2014-050.02375
2014-080.02473
2014-110.02355
2015-020.02529
2015-050.02277
2015-080.02406
2015-110.02232
2016-020.02331
2016-050.02385
2016-080.02290
2016-110.02343
2017-020.02428
2017-050.02486
2017-080.02511
2017-110.02392
2018-020.02208
2018-050.02306
2018-080.02342
2018-110.02329
2019-020.02391
2019-050.02472
2019-080.02586
2019-110.02513
2020-020.02442
2020-050.02668
2020-080.02500
2020-110.02573
2021-020.02481
2021-050.02606
2021-080.02451
2021-110.02474
2022-020.02280
2022-050.02337
2022-080.02315
2022-110.02377
2023-020.02018
2023-050.02117
2023-080.02198
2023-110.02251
2024-020.02132
2024-050.01727
2024-080.01881
2024-110.01682
2025-020.01690
2025-050.01781
2025-080.01927
2025-110.01828
2026-020.01790
2026-050.01764
2026-080.01713
2026-110.01723

Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.

Recall records mentioning cyclobenzaprine

openFDA enforcement records, by year reported.

20251
20213
20181
20171
20151
20141

8 records since 2012. A record is one product or lot, not one recall event. Combination products that contain cyclobenzaprine are included.

What these numbers mean

NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.

Most recent recall records

Class IOngoing
Cyclobenzaprine hydrochloride tablets
Reason category: Labeling or packaging error
FDA recall number D-0655-2025
Class IITerminated
Cyclobenzaprine product
Reason category: Sterility / contamination
FDA recall number D-0774-2021
Class IITerminated
Cyclobenzaprine product
Reason category: Sterility / contamination
FDA recall number D-0775-2021
Class IITerminated
Cyclobenzaprine product
Reason category: Sterility / contamination
FDA recall number D-0776-2021
Class IITerminated
Cyclobenzaprine hcl usp for prescription compounding
Reason category: cGMP deviations
FDA recall number D-0481-2018

Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.

Articles that mention cyclobenzaprine

2 GxRadar articles cite or discuss this drug.

Using medicines safely · Explainer · 6 min

Look-alike and sound-alike drug names, and how FDA tries to keep them apart

How FDA screens new drug names with its POCA software, why generic names can resemble each other, how tall man lettering works, and what recall records show about mix-ups.

PRICE INDEX · 2014 = 100
Price histories · Data story · 5 min

The cheapest pills in GxRadar's 47-drug price basket

Seven of the 47 generics we track cost pharmacies under 2 cents a unit in October 2026, led by amlodipine at 1.02 cents. Which drugs sit at the floor, how long they have been there, and what the ranking does not show.